Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy - Contacts and Locations

Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy

This study is currently recruiting participants.

Study NCT00072137. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00072137

Locations


United States, New Jersey
	Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School	Recruiting
	New Brunswick, New Jersey, United States, 08903
	Contact: Clinical Trials Office - Cancer Institute of New Jersey 732-235-8675

Sponsors and Collaborators

Cancer Institute of New Jersey

National Cancer Institute (NCI)

Investigators


Study Chair:	Edmund C. Lattime, PhD	Cancer Institute of New Jersey